Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors.

MLA

Seal, Jonathan T., et al. “Fragment-Based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors.” Journal of Medicinal Chemistry, vol. 64, no. 15, Aug. 2021, pp. 10772–805. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.1c00365.

APA

Seal, J. T., Atkinson, S. J., Bamborough, P., Bassil, A., Chung, C.-W., Foley, J., Gordon, L., Grandi, P., Gray, J. R. J., Harrison, L. A., Kruger, R. G., Matteo, J. J., McCabe, M. T., Messenger, C., Mitchell, D., Phillipou, A., Preston, A., Prinjha, R. K., Rianjongdee, F., … Demont, E. H. (2021). Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors. Journal of Medicinal Chemistry, 64(15), 10772–10805. https://doi.org/10.1021/acs.jmedchem.1c00365

Chicago

Seal, Jonathan T, Stephen J Atkinson, Paul Bamborough, Anna Bassil, Chun-Wa Chung, James Foley, Laurie Gordon, et al. 2021. “Fragment-Based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors.” Journal of Medicinal Chemistry 64 (15): 10772–805. doi:10.1021/acs.jmedchem.1c00365.